NEW YORK, NY / ACCESSWIRE / December 19, 2019 / Healthcare Solutions Holdings, a medical service and device company focused on providing clinicians with state-of-the-art diagnostic and therapeutic tools announced the appointment of Richard Muckerman, MD, as member of the Medical Advisory Board.

Dr. Richard Muckerman

"We are excited to welcome Dr. Richard Muckerman to our Medical Advisory Board." said Travis Revelle, Chief Executive Officer of Healthcare Solutions Holdings. "Dr. Muckerman is a recognized leader in the Obstetrics and Gynecology specialty. His experience will be invaluable as we continue to commercialize products focused on improving the women's health market."

Dr. Richard Muckerman attended Georgetown University where he received a B.S. in Biology then received his Medical Degree from Georgetown University School of Medicine. He completed both his internship and residency at St. John's Mercy Medical Center, completing the OB/GYN Residency program and serving as Chief Resident. Dr. Muckerman is an expert in general obstetrics and performs both inpatient and outpatient surgeries. He has a special interest in hereditary cancer risk assessment and breast cancer risk assessment, and each of his patients is offered this assessment. He is a proponent of independent physicians and was the founding physician and initial medical director for St. Louis Women's Surgery Center. He believes in helping physicians remain independent so they can control their destiny. Dr. Muckerman is a Board Certified OBGYN as well as a fellow of the American College of OBGYN.

"HSI believes in helping independent physician groups by providing multiple service lines with cost-effective lab testing, pharmacy options, and medical devices," says Dr. Muckerman. "HSI is willing to compete with some of the larger healthcare companies in the United States and they're doing it by providing cutting edge technology and efficiency- all at a low cost. There is opportunity to compete because the independent physicians can provide lower cost alternatives to patients compared to hospitals, which benefits health care consumers in the United States. HSI currently offers multiple service lines under one umbrella and with this model I believe they will be able to help physicians. At HSI, physicians have one point of contact to assist with multiple products, which provides more efficiency for physicians and their office staff. Any business that can help physicians remain independent has my support."

HSI is a medical service, and device company focused on providing clinicians with state-of-the-art diagnostic and therapeutic tools. Our mission is to improve patient outcomes by helping clinicians gain broader access to the most advanced technology in the healthcare industry. HSI does not only focus on assisting physicians with exceptional healthcare delivery, but also promoting compliance with the industry's best practices.

Healthcare Solutions, Inc., headquartered in Glen Cove, New York. Please visit www.hscorp.biz for additional information.

CONTACT:

Jonathan Loutzenhiser
SVP Healthcare Solutions
Email: IR@HScorp.Biz
Email: MR@HScorp.Biz
Phone: +1 (866) 668-2188

SOURCE: Healthcare Solutions Holdings, Inc.

ReleaseID: 570883

NEW YORK, NY / ACCESSWIRE / December 19, 2019 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

Under Armour, Inc. (NYSE:UA)

Investors Affected : August 3, 2016 – November 1, 2019

A class action has commenced on behalf of certain shareholders in Under Armour, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Under Armour shifted sales from quarter to quarter to appear healthier, including to keep pace with their long-running year-over-year 20% net revenue growth; (2) undisclosed to the investing public, the Company had been under investigation by and cooperating with the U.S. Department of Justice and U.S. Securities and Exchange Commission since at least July 2017; and (3) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/under-armour-inc-loss-submission-form/?id=4976&from=1

Mylan N.V. (NASDAQ:MYL)

Investors Affected : May 9, 2018 – May 6, 2019

A class action has commenced on behalf of certain shareholders in Mylan NV. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Mylan’s Morgantown facility was in significant violation of the FDA’s Current Good Manufacturing Practice regulations; (2) Mylan would need to engage in a massive restructuring and remediation program; (3) Mylan’s North American Segment would be substantially impacted by said program, which would in turn materially impact Mylan’s financial health; (3) Mylan lacked effective internal control over financial reporting; and (4) as a result of the foregoing, the Company’s financial statements were materially false and misleading at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/mylan-n-v-loss-submission-form/?id=4976&from=1

Armstrong Flooring, Inc. (NYSE:AFI)

Investors Affected : March 6, 2018 – November 4, 2019

A class action has commenced on behalf of certain shareholders in Armstrong Flooring, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the Company had engaged in channel stuffing to artificially boost sales; (2) the Company’s internal control over inventory levels was not effective; and (3) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis

Shareholders may find more information at https://securitiesclasslaw.com/securities/armstrong-flooring-inc-loss-submission-form/?id=4976&from=1

The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (212) 537-9430
Fax: (833) 862-7770

SOURCE: The Gross Law Firm

ReleaseID: 570882

NEW YORK, NY / ACCESSWIRE / December 19, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Adamas Pharmaceuticals, Inc. (NASDAQGM: ADMS)
Class Period: August 8, 2017 to September 30, 2019
Lead Plaintiff Deadline: February 10, 2020

The ADMS lawsuit alleges that throughout the class period, Adamas Pharmaceuticals, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) health insurers were excluding Adamas's primary product, GOCOVRI, from their prescription formularies or requiring patients to use "step therapy" – i.e., making patients try immediate-release amantadine prior to covering GOCOVRI; (2) the rapid increase in physicians prescribing GOCOVRI during the Class Period was not due to its efficacy; and (3) as a result of the foregoing, the Company's financial statements about Adamas's business, operations, and prospects were materially false and misleading at all relevant times.

Learn about your recoverable losses in ADMS: http://www.kleinstocklaw.com/pslra-1/adamas-pharmaceuticals-inc-loss-submission-form?id=4975&from=1

Twitter, Inc. (NYSE: TWTR)
Class Period: August 6, 2019 to October 23, 2019
Lead Plaintiff Deadline: December 30, 2019

The filed complaint alleges that defendants engaged in a scheme to deceive the market and a course of conduct that artificially inflated Twitter's common share price and operated as a fraud or deceit on purchasers of Twitter common stock by misrepresenting the Company's operating condition and future business prospects. The scheme was perpetrated by making positive statements about Twitter's business while defendants knew, or disregarded with deliberate recklessness, certain adverse facts. When defendants' prior misrepresentations were disclosed and became apparent to the market, the price of Twitter's common stock fell precipitously.

Learn about your recoverable losses in TWTR: http://www.kleinstocklaw.com/pslra-1/twitter-inc-loss-submission-form?id=4975&from=1

Baozun Inc. (NASDAQ: BZUN)
Class Period: Baozun American Depository Receipts between March 6, 2019 and November 20, 2019
Lead Plaintiff Deadline: February 10, 2020

The complaint alleges that during the class period Baozun Inc. made materially false and/or misleading statements and/or failed to disclose that: (a) Baozun was heavily reliant upon a single brand partner, Huawei, for the exponential service fee growth it had been reporting historically, which was in turn fueling its historical revenue growth; (b) compared to other brands Baozun had as brand partners, the Huawei work had historically included a lot of additional add-on service fees, increasing the revenue reported from Huawei vis-a-via its other brand partners; (c) Huawei, like other large brands, was actively preparing to bring its online merchandising in-house, meaning Baozun knew that it was losing a significant brand partner; and (d) as a result of the foregoing, the Company was not on track to achieve the financial results and performance Defendants claimed the Company was on track to achieve during the class period.

Learn about your recoverable losses in BZUN: http://www.kleinstocklaw.com/pslra-1/baozun-inc-loss-submission-form?id=4975&from=1

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm

ReleaseID: 570877

Not for Distribution to U.S. News Wire Services or Dissemination in the United States

CALGARY, AB / ACCESSWIRE / December 19, 2019 / Petrodorado Energy Ltd. ("Petrodorado" or the "Company") (TSXV:PDQ) announces that further to its recently held annual general and special meeting of shareholders, approval was received for a change of name of the Company. The Board of Directors has decided to amalgamate the Company with its wholly-owned subsidiary, ROK Resources Inc. and to continue to use the name "ROK Resources Inc." for the name of the amalgamated company, subject to the approval of the TSX Venture Exchange regarding same. The amalgamation is scheduled to take effect on January 1, 2020. As part of the name change, the Company will be changing its ticker symbol to "ROK". The Company expects to start trading under the new ticker symbol on the facilities of the TSX Venture Exchange at the open of the markets on January 2, 2020. The Company has received a new CUSIP number for its Class B common shares which are associated with the new name. Shareholders do not need to tender their existing shares as the transfer agent will be pushing out the new shares to all existing shareholders.

About Petrodorado

Petrodorado was previously engaged in petroleum and natural gas exploration and development activities in Colombia and is currently engaged in exploring for petroleum and natural gas development activities in Saskatchewan. Its head office is located in Regina, Saskatchewan, Canada and Petrodorado's common shares are traded on the Exchange under the trading symbol "PDQ".

For further information, please contact:

Cameron Taylor, President and CEO
Lynn Chapman, VP Finance and CFO Phone: (306) 698-7999
Email: info@rokresources.ca

Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility of the adequacy or accuracy of this release.

SOURCE: Petrodorado Energy Ltd.

ReleaseID: 570848

NEW YORK, NY / ACCESSWIRE / December 19, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

AZZ Shareholders Click Here: https://www.zlk.com/pslra-1/azz-inc-loss-form?prid=4974&wire=1
GRUB Shareholders Click Here: https://www.zlk.com/pslra-1/grubhub-inc-loss-form?prid=4974&wire=1
EXC Shareholders Click Here: https://www.zlk.com/pslra-1/exelon-corporation-loss-form?prid=4974&wire=1

* ADDITIONAL INFORMATION BELOW *

Azz, Inc. (NYSE:AZZ)

AZZ Lawsuit on behalf of: investors who purchased July 3, 2018 – October 8, 2019
Lead Plaintiff Deadline: January 3, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/azz-inc-loss-form?prid=4974&wire=1

According to the filed complaint, during the class period, Azz, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company's internal controls over financial reporting were not effective; (2) the Company improperly implemented ASC 606 which resulted in improper revenue reconciliations; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Grubhub Inc. (NYSE:GRUB)

GRUB Lawsuit on behalf of: investors who purchased July 30, 2019 – October 28, 2019
Lead Plaintiff Deadline: January 20, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/grubhub-inc-loss-form?prid=4974&wire=1

According to the filed complaint, during the class period, Grubhub Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) customer orders were actually declining, despite the massive investments that the Company had made to spur demand for and use of its platform; (ii) Grubhub's new customer additions were generating significantly lower revenues as compared to historic cohorts because these customers were more prone to using competitor platforms; (iii) Grubhub's vaunted business model under which it secured exclusive partnerships had failed, and Grubhub needed to engage in the same aggressive nonpartnered sales tactics embraced by its competitors to generate significant revenue growth; (iv) Grubhub was required to spend substantial additional capital in order to grow revenues and retain market share in the face of heightened competitive dynamics and market saturation, eviscerating the Company's profitability; and (v) Grubhub was tracking tens of millions of dollars below its revenue and earnings guidance and such guidance lacked any reasonable basis.

Exelon Corporation (NYSE:EXC)

EXC Lawsuit on behalf of: investors who purchased February 9, 2019 – November 1, 2019
Lead Plaintiff Deadline: February 14, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/exelon-corporation-loss-form?prid=4974&wire=1

According to the filed complaint, during the class period, Exelon Corporation made materially false and/or misleading statements and/or failed to disclose that: (i) Exelon and/or its employees were engaged in unlawful lobbying activities; (ii) the foregoing increased the risk of a criminal investigation into Exelon; (iii) Exelon subsidiary Commonwealth Edison's revenues were in part the product of unlawful conduct and thus unsustainable; and (iv) that, as a result, the Company's public statements were materially false and misleading at all relevant times.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 570875

LOS ANGELES, CA / ACCESSWIRE / December 19, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Uniti Group Inc. ("Uniti" or "the Company") (NASDAQ:UNIT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's securities between April 20, 2015 and February 15, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before December 30, If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Uniti's customer, Windstream, defaulted on unsecured notes, rendering the Company's financial results unsustainable. Based on this fact, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Uniti, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 570872

LOS ANGELES, CA / ACCESSWIRE / December 19, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Sealed Air Corporation ("Sealed Air" or "the Company") (NYSE:SEE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission."

Investors who purchased the Company's securities between November 5, 2014 and August 6, 2018, inclusive (the ''Class Period''), are encouraged to contact the firm before December 31, 2019.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Sealed Air improperly deducted $1.49 billion related to the settlement of asbestos liabilities from its taxes to artificially inflate its financial performance. The Company switched auditors to help facilitate this fraud. On August 6, 2018, the Company admitted that it had received a subpoena from the SEC related to the Company's accounting for taxes and financial disclosures. Based on these facts, the company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Sealed Air, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 570871

LOS ANGELES, CA / ACCESSWIRE / December 19, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against AZZ Inc. ("AZZ" or "the Company") (NYSE:AZZ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's securities between July 3, 2018 and October 8, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before January 3, 2020.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. AZZ failed to maintain appropriate and effective controls on financial reporting. The Company's improper implementation of ASC 606 resulted in incorrect revenue reconciliations. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about AZZ, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 570869

LOS ANGELES, CA / ACCESSWIRE / December 19, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Armstrong Flooring, Inc. ("Armstrong" or "the Company") (NYSE:AFI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's securities between March 6, 2018 and November 4, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before January 14, 2020.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Armstrong artificially boosted its sales using a channel stuffing scheme. The Company failed to maintain effective controls on inventory. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Armstrong, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 570868

CALGARY, AB / ACCESSWIRE / December 19, 2019 / Poplar Creek Resources Inc. (the "Corporation") announces that effective December 19, 2019, Steve Meszaros was appointed as a director of the Corporation.

Mr. Meszaros has been involved in real estate sales, land acquisitions and developments and operating Avonlea Homes, a residential construction company in Lethbridge, Alberta. He sold his interest in Avonlea Homes in 2015.

For further information contact;

Poplar Creek Resources Inc.
Attention: Richard Edgar
Chief Executive Officer
Phone: (403) 616-5387
E-mail: redgarex@gmail.com

SOURCE: Poplar Creek Resources Inc.

ReleaseID: 570862